Oracle Corporation
Rating
Accumulate
Adding on Dips — Active Accumulation
Combined average of Moat (AI Resilience), Growth, and Valuation scores.
Moat Score
Decades of mission-critical database embedding at the world's largest enterprises create switching costs so high that migration is measured in years, not months.
Oracle operates a Mission-Critical Lock-In Machine built on four interlocking advantages:
- Database Embedding So Deep It Becomes Infrastructure: Oracle Database runs the core financial, ERP, and operational systems of most Global 2000 companies. Migrating away requires rewriting thousands of stored procedures, custom PL/SQL logic, and application integrations — a multi-year, nine-figure project with high failure risk. The switching cost is not a feature; it is the moat.
- OCI as the AI Cloud Challenger: Oracle Cloud Infrastructure (OCI) grew 93% YoY to $5.8B in Q4 FY2026 (accelerating from 84% in Q3) and is winning hyperscale AI workloads from OpenAI, xAI, Meta, NVIDIA, and AMD due to superior GPU cluster networking and pricing. The $638B remaining performance obligations backlog — up 363% YoY and +$85B sequentially — signals that OCI has become a genuine tier-2 cloud with tier-1 AI infrastructure ambitions, though management notes most of the Q3/Q4 RPO additions are large-scale AI contracts where customers prepaid for GPUs or supplied GPUs to Oracle. Oracle has secured 10+ gigawatts of power and data center capacity.
- Autonomous Database Extends the Moat: Oracle Autonomous Database automatically patches, tunes, and secures itself using machine learning — removing the DBA bottleneck while increasing dependency on Oracle's specific platform. Customers moving to Autonomous Database become more locked in, not less, as the AI-managed complexity discourages migration.
- Cloud ERP Landgrab via Fusion and Cerner: Oracle Fusion Cloud ERP is taking share from SAP in enterprise resource planning. The Cerner acquisition added the largest healthcare IT installed base in the US — embedding Oracle into the record-keeping infrastructure of thousands of hospitals and health systems, creating a second major system-of-record moat in a regulated industry. Headwinds persist: Oracle Health's acute care EHR market share has slipped to 22.9% (vs Epic's 42.3%), with 74 hospitals departing in 2024. Oracle's response — a next-gen OCI-native EHR with AI and voice capabilities — is expected in acute care form in 2026, alongside resumed VA rollout with improving satisfaction scores.
Ten Moats Verdict
Oracle is highly AI-resilient and is itself becoming an AI infrastructure hyperscaler. Its deepest moat — database embedding — is structural and physical, not software-replicable. OCI's rise as AI training infrastructure is additive rather than disruptive to the core. The $638B RPO backlog (Q4 FY2026, +363% YoY), 93% OCI growth, Stargate partnership, and expanding federal government entrenchment (Top Secret/SCI, DISA IL5/IL6) position Oracle as one of the most extraordinary growth-plus-moat combinations in enterprise technology. The near-term FCF drag from $55.7B FY2026 capex and Oracle Health market share erosion vs Epic are the primary risks; the 30,000-person restructuring announced March 2026 should materially improve the FCF profile from FY2028 onward.
Oracle SQL, PL/SQL, and APEX are deeply learned by hundreds of thousands of enterprise developers. Institutional knowledge baked into development teams is a real switching cost even before touching migration complexity.
Oracle databases store decades of enterprise business logic in stored procedures, triggers, and custom PL/SQL — logic that is nearly impossible to fully document or migrate without business disruption. This is one of the most powerful switching costs in software.
N/A — not a source of competitive advantage for Oracle's core business; its data moat is proprietary customer data stored within Oracle systems.
Certified Oracle DBAs and Fusion ERP consultants are scarce and expensive. The partner ecosystem of implementation firms (Deloitte, Accenture, KPMG) certified on Oracle products reinforces adoption inertia.
Oracle bundles database, cloud infrastructure, ERP, HCM, SCM, CX, and analytics under a single enterprise license — creating a platform effect that is cheaper to stay within than to unbundle across best-of-breed alternatives.
Oracle systems store the most sensitive and mission-critical enterprise data in the world — financials, HR records, supply chain, and clinical data. This data residency creates deep compliance and operational dependency.
Cerner (Oracle Health) serves as the EHR system for thousands of US hospitals subject to HIPAA, CMS interoperability, and ONC certification requirements — existing customers face multi-year, nine-figure migration projects to switch. OCI's expanding federal footprint (FedRAMP High, DISA IL5/IL6, NSA Top Secret/SCI authorization, $88M Air Force Cloud One contract) and the Oracle AI Data Platform for US Federal Agencies (March 2026) deepen government entrenchment. Oracle Health acute care market share erosion (22.9%, down from ~25% in 2021) is a concern for new wins, but does not materially reduce lock-in for the existing 2,000+ hospital installed base.
Oracle's partner certification ecosystem and ISV integrations create indirect network effects — more certified implementation partners make Oracle easier to adopt — but these are not classic two-sided network effects.
Oracle Database processes the financial transactions, clinical records, and operational events of most Global 2000 companies. It is not adjacent to mission-critical transactions — it IS the transaction layer.
Oracle is the definitive system of record for enterprise finance, HR, and operations at thousands of the world's largest organizations. No other software vendor occupies this position at comparable scale.
Combined average of Moat (AI Resilience), Growth, and Valuation scores.
Moat Score
Decades of mission-critical database embedding at the world's largest enterprises create switching costs so high that migration is measured in years, not months.
Growth Score
Q4 FY2026 (reported June 10, 2026) was a record close to the fiscal year: total revenue $19.2B (+21% YoY), total cloud revenue $9.9B (+47%), OCI infrastructure $5.8B (+93%, accelerating from +84% in Q3), and RPO of $638B (+363% YoY, +$85B sequentially). FY2026 finished at $67.4B (+17%) with cloud revenue of $34.0B (+39%); non-GAAP Q4 EPS $2.11 (+24%) beat estimates. FY2027 revenue guidance of $90B (+34% CC) was reaffirmed/raised, with Q1 FY27 cloud revenue guided +58–64%. The stock fell after hours as FY2026 capex reached $55.7B, reigniting the FCF debate. A 30,000-person restructuring (March 31, 2026) is expected to yield $8-10B in incremental annual FCF. AI training workload demand remains the primary acceleration vector; note most recent RPO additions are GPU-prepaid or customer-supplied-GPU AI contracts.
Valuation Score
At ~$192 (June 10, 2026 session; shares slipped after hours post-Q4 on the $55.7B capex print), Oracle has rallied ~37% from the ~$140 April level and now sits just 4% below the base case ($200) — the accumulation window below $150 has closed. Q4 FY2026 validated the thesis (OCI +93%, RPO $638B +363%, FY27 guided to $90B / +34% CC), but the price has largely caught up to the base scenario; further upside requires bull-case execution (Stargate acceleration, 20%+ AI training share). FCF remains negative due to the $55.7B FY2026 capex cycle.
The Database Hostage Moat
Oracle operates a Mission-Critical Lock-In Machine built on four interlocking advantages:
- Database Embedding So Deep It Becomes Infrastructure: Oracle Database runs the core financial, ERP, and operational systems of most Global 2000 companies. Migrating away requires rewriting thousands of stored procedures, custom PL/SQL logic, and application integrations — a multi-year, nine-figure project with high failure risk. The switching cost is not a feature; it is the moat.
- OCI as the AI Cloud Challenger: Oracle Cloud Infrastructure (OCI) grew 93% YoY to $5.8B in Q4 FY2026 (accelerating from 84% in Q3) and is winning hyperscale AI workloads from OpenAI, xAI, Meta, NVIDIA, and AMD due to superior GPU cluster networking and pricing. The $638B remaining performance obligations backlog — up 363% YoY and +$85B sequentially — signals that OCI has become a genuine tier-2 cloud with tier-1 AI infrastructure ambitions, though management notes most of the Q3/Q4 RPO additions are large-scale AI contracts where customers prepaid for GPUs or supplied GPUs to Oracle. Oracle has secured 10+ gigawatts of power and data center capacity.
- Autonomous Database Extends the Moat: Oracle Autonomous Database automatically patches, tunes, and secures itself using machine learning — removing the DBA bottleneck while increasing dependency on Oracle's specific platform. Customers moving to Autonomous Database become more locked in, not less, as the AI-managed complexity discourages migration.
- Cloud ERP Landgrab via Fusion and Cerner: Oracle Fusion Cloud ERP is taking share from SAP in enterprise resource planning. The Cerner acquisition added the largest healthcare IT installed base in the US — embedding Oracle into the record-keeping infrastructure of thousands of hospitals and health systems, creating a second major system-of-record moat in a regulated industry. Headwinds persist: Oracle Health's acute care EHR market share has slipped to 22.9% (vs Epic's 42.3%), with 74 hospitals departing in 2024. Oracle's response — a next-gen OCI-native EHR with AI and voice capabilities — is expected in acute care form in 2026, alongside resumed VA rollout with improving satisfaction scores.
Ten Moats Verdict
Oracle is highly AI-resilient and is itself becoming an AI infrastructure hyperscaler. Its deepest moat — database embedding — is structural and physical, not software-replicable. OCI's rise as AI training infrastructure is additive rather than disruptive to the core. The $638B RPO backlog (Q4 FY2026, +363% YoY), 93% OCI growth, Stargate partnership, and expanding federal government entrenchment (Top Secret/SCI, DISA IL5/IL6) position Oracle as one of the most extraordinary growth-plus-moat combinations in enterprise technology. The near-term FCF drag from $55.7B FY2026 capex and Oracle Health market share erosion vs Epic are the primary risks; the 30,000-person restructuring announced March 2026 should materially improve the FCF profile from FY2028 onward.
Oracle SQL, PL/SQL, and APEX are deeply learned by hundreds of thousands of enterprise developers. Institutional knowledge baked into development teams is a real switching cost even before touching migration complexity.
Oracle databases store decades of enterprise business logic in stored procedures, triggers, and custom PL/SQL — logic that is nearly impossible to fully document or migrate without business disruption. This is one of the most powerful switching costs in software.
N/A — not a source of competitive advantage for Oracle's core business; its data moat is proprietary customer data stored within Oracle systems.
Certified Oracle DBAs and Fusion ERP consultants are scarce and expensive. The partner ecosystem of implementation firms (Deloitte, Accenture, KPMG) certified on Oracle products reinforces adoption inertia.
Oracle bundles database, cloud infrastructure, ERP, HCM, SCM, CX, and analytics under a single enterprise license — creating a platform effect that is cheaper to stay within than to unbundle across best-of-breed alternatives.
Oracle systems store the most sensitive and mission-critical enterprise data in the world — financials, HR records, supply chain, and clinical data. This data residency creates deep compliance and operational dependency.
Cerner (Oracle Health) serves as the EHR system for thousands of US hospitals subject to HIPAA, CMS interoperability, and ONC certification requirements — existing customers face multi-year, nine-figure migration projects to switch. OCI's expanding federal footprint (FedRAMP High, DISA IL5/IL6, NSA Top Secret/SCI authorization, $88M Air Force Cloud One contract) and the Oracle AI Data Platform for US Federal Agencies (March 2026) deepen government entrenchment. Oracle Health acute care market share erosion (22.9%, down from ~25% in 2021) is a concern for new wins, but does not materially reduce lock-in for the existing 2,000+ hospital installed base.
Oracle's partner certification ecosystem and ISV integrations create indirect network effects — more certified implementation partners make Oracle easier to adopt — but these are not classic two-sided network effects.
Oracle Database processes the financial transactions, clinical records, and operational events of most Global 2000 companies. It is not adjacent to mission-critical transactions — it IS the transaction layer.
Oracle is the definitive system of record for enterprise finance, HR, and operations at thousands of the world's largest organizations. No other software vendor occupies this position at comparable scale.
Growth Analysis
Growth Drivers
Key Risk
The $90B FY27 target depends on AI training demand staying durable through a multi-year $55B+/year capex cycle (FY2026 capex $55.7B) funded against a rising debt load ($30B of a planned $50B financing package already raised). Most Q3/Q4 RPO additions are GPU-prepaid or customer-supplied-GPU AI contracts, so the $638B headline overstates organic, margin-rich backlog. If hyperscaler AI capex digestion arrives sooner than the OCI backlog converts, or if OCI AI infrastructure gross margins remain below 35% through FY2028, the FCF inflection thesis fails and the valuation re-rates against an over-levered cyclical balance sheet rather than a compounder.
Score Derivation
Base 80 (15-30% CAGR: FY2026 $67.4B actual → FY2027 $90B guided = +34% CC; FY2025→FY2027 ~25% 2-yr CAGR) + 5 recurring (OCI subscriptions + ERP NRR >110%) + 5 TAM expansion (AI training cloud $200B+ TAM by 2027) − 2 FCF profile (negative FCF during $55.7B FY2026 capex cycle) = 88
Key Growth Catalysts
Price Scenarios (12–24 Months)
Valuation Analysis
Oracle's contracted RPO backlog of $638B — up 363% YoY — provides extraordinary earnings visibility, though most recent additions are GPU-prepaid or customer-supplied-GPU AI contracts. The $55.7B FY2026 capex cycle is depressing near-term FCF, but Guggenheim and other analysts see a 'free cash flow waterfall' materializing in FY2029-2030. FY2027 revenue guidance of $90B implies +34% CC growth from FY2026's $67.4B actual. A new CFO (Hilary Maxson, appointed April 6, 2026) brings industrial capital allocation experience suited to managing the AI infrastructure buildout. $200.
Valuation Multiples
| Trailing P/E (GAAP) | ~34× |
| Forward P/E (NTM) | ~24× |
| PEG Ratio | ~1.3× |
| Price / Sales (NTM) | ~6.4× |
| Price / FCF | N/A |
At ~$192, ORCL trades at ~24× FY2027 forward earnings — now roughly in line with the enterprise software peer median (~25×) after the 37% rally from April. The growth-at-a-discount setup (PEG ~0.94 at $140) has normalised to a fair ~1.3× PEG; the market is now paying for the $638B RPO conversion rather than discounting execution risk. The gap between trailing (~34×) and forward (~24×) still reflects the substantial earnings ramp expected in FY2027 as OCI revenues scale (+93% in Q4 FY26, Q1 FY27 cloud guided +58–64%) and restructuring savings flow through.
Approximate figures as of June 2026 (post-Q4 FY2026, price ~$192).
Where We Are vs Targets
Loading live price…
OCI loses AI infrastructure share to AWS and Azure, the $553B RPO proves overcommitted, and the $50B capex cycle produces stranded assets rather than revenue.
- AWS Trainium and Azure custom silicon erode OCI's GPU networking advantage; RPO contracts include customer-supplied GPU provisions that inflate headline backlog
- Oracle Fusion ERP implementations underperform expectations, triggering high-profile churn
- Legacy database support revenue declines 5%+ annually as AWS Aurora and PostgreSQL migrations accelerate
- Cerner integration costs and healthcare IT complexity drag margins below 25%
OCI sustains 50%+ growth as a primary AI training cloud, Fusion ERP and NetSuite compound steadily, and revenue reaches $90B in FY2027 as guided.
- OCI grows toward $18B annual revenue in FY2026 (guided 77% growth), then $32B and beyond through FY2028-2030
- Oracle Fusion Cloud ERP achieves $10B+ in annual revenue with industry-leading NRR
- Autonomous Database adoption increases renewal rates and reduces churn in the installed base
- Cerner becomes a $10B+ revenue segment as AI clinical applications roll out across 1,000+ hospitals
OCI emerges as the dominant AI training cloud serving Stargate and sovereign AI deployments, Oracle Health transforms clinical workflows, and $553B RPO converts to revenue faster than expected.
- OCI wins 20%+ of the AI training infrastructure market, rivaling AWS and Azure in GPU density; 10+ GW of secured capacity comes online ahead of schedule
- Stargate buildout accelerates OCI revenue well beyond the $90B FY2027 guidance
- Oracle Health AI platform becomes standard across US hospital systems, unlocking $20B+ revenue potential
- SAP migration wave to Oracle Fusion ERP accelerates post-SAP S/4HANA end-of-life cycle